Item 1. Financial Statements and Notes
Notes
to the Financial Statements
Six-Month
Period ended June 30, 2014
(Unaudited)
Note
1 – Description of Business and Summary of Significant Accounting Policies
Description
of Business
Arista
Power, Inc. (the “Company”) was incorporated on March 30, 2001 in the State of New York as Future Energy Solutions,
Inc. and in November 2008 changed its name to WindTamer Corporation. In May 2011, the Company changed its name to Arista Power,
Inc. The name change more accurately reflects the broadening of the Company’s focus beyond the WindTamer® brand and
entry into areas within the energy storage and power management industries.
The
Company is a developer, integrator, and supplier of custom-designed power management systems, and a supplier, designer and installer
of solar energy systems. The Company’s patent-pending Power on Demand system utilizes inputs from multiple energy
sources including solar, wind, fuel cells, generators, and the grid, in conjunction with a custom-designed battery storage system
and a proprietary smart monitoring technology that releases energy at optimal times to reduce electricity costs for large energy
users. The Company also designs, sells and installs residential and commercial solar PV systems.
Basis
of Preparation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly,
they do not include all of the information required by GAAP for complete annual financial statement presentation.
In the opinion of management, all adjustments
(consisting only of normal and recurring adjustments) necessary for a fair presentation of the results of operations have
been included in the accompanying unaudited condensed financial statements. Operating results for the three months
and six month periods ended June 30, 2014 are not necessarily indicative of the results to be expected for other interim
periods or the full fiscal year. These financial statements should be read in conjunction with the financial
statements and accompanying notes contained in the Arista Power Form 10-K for the fiscal year ended December 31, 2013.
Method
of Accounting
The
accompanying financial statements have been prepared in accordance with GAAP. Arista Power maintains its books and
prepares its financial statements on the accrual basis of accounting.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ
from those estimates.
Cash
and Cash Equivalents
For
financial statement presentation purposes, the Company considers all short-term, highly liquid investments with original maturities
of three months or less to be cash and cash equivalents. The Company maintains its cash and cash equivalents in bank
deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant
credit risk as a result of any non-performance by the financial institutions.
Accounts
Receivable
Accounts
receivable represents amounts due from customers in the ordinary course of business, based upon invoiced amounts, net of any allowance
for doubtful accounts. We evaluate accounts receivable quarterly on a specific account basis to determine the need
to an allowance for doubtful account reserve. As of June 30, 2014 and December 31, 2013, the allowance for doubtful
accounts was $0.
Inventory
Inventory
consists primarily of parts and subassemblies for Power on Demand systems, solar photovoltaic (“PV”) systems, and
is stated at the lower of cost or market value. The Company capitalizes applicable direct and indirect costs incurred
in the Company’s manufacturing operations to bring its products to a sellable state. The inventory as of June
30, 2014 consisted of raw materials amounting to $346,014 and work-in-process amounting to $150,299. Inventory is reviewed
quarterly to determine the need for an excess and obsolete inventory reserve. As of June 30, 2014 and December 31,
2013, no reserve was necessary.
Fixed
Assets
Fixed
assets are recorded at cost. Depreciation is on a straight line basis over the shorter of the estimated useful lives
or the related lease for leasehold improvements. Leasehold improvements for space leased on a month-to-month basis
are expensed when incurred. Expenditures for renewals and betterments are capitalized. Expenditures for
minor items, repairs and maintenance are charged to operations as incurred. Any gain or loss upon sale or retirement due
to obsolescence is reflected in the operating results in the period the event takes place.
Intangible
Assets
Intangible assets consist of costs associated with the application
and acquisition of the Company’s patents. Patent application costs are capitalized and amortized over the estimated
useful life of the patent, which generally approximates its legal life. For the three and six months ended June 30, 2013, trademark
costs totaling $0 and $3,396, respectfully relating to the Company’s WindTamer® trademark were impaired, while no intangible
assets were impaired for the six and three months ended June 30, 2014.
Impairment
of Long-Lived Assets
Long-lived
assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may
not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of an asset to future net undiscounted cash flows expected to be generated by the asset, including its ultimate disposition. If
such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Fair value is determined based on discounted cash flows or appraised
values, depending on the nature of the assets. For the six and three months ended June 30, 2014 and 2013, no assets
were impaired.
Fair
Value of Financial Instruments
The
carrying amount of cash, accounts receivable, accounts payable and accrued expenses are reasonable estimates of their fair value
due to their short maturity.
Revenue
Recognition
Revenue
is recognized when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement;
(2) the service or product has been provided to the customer; (3) the sale price to be paid by the customer is fixed or determinable;
and (4) the collection of the sale price is reasonably assured. Amounts collected prior to satisfying our revenue
recognition policy are reflected as customer deposits.
For
research and development contracts, we recognize the revenue using the proportional effort method based upon the relationship
of costs incurred to date to the total estimated cost to complete the contract. Cost elements include direct labor, materials,
overhead costs and outside contractor costs. The excess of amounts billed on a milestone basis versus the amounts recorded
as revenue on a proportional effort basis is classified as deferred revenue. We provide for any loss that we expect to incur in
the agreements when the loss is probable.
The Company uses contract accounting for Power on Demand
system sales. Due to the limited number of these systems that have been installed to date, revenue is recognized based on the completed
contract method whereby revenue and costs are deferred until the contract is completed. For contracts that contain provisions related
to proceeds being paid based upon cost savings generated by the system, revenue is recorded as the costs savings are realized by
and billed to the customer. If accumulated costs exceed accumulated billings at the reporting date the asset is presented net as
costs of uncompleted contracts in excess of related billings. If there is a net liability it is presented as billings on uncompleted
contracts in excess of related costs. We provide for any loss that we expect to incur on a contract at the time the loss is probable.
At June 30, 2014 the Company had costs of uncompleted contracts
in excess of related billings totaling $217,229 ($0 as of June 30, 2013). This amount was netted with the accrued loss contract
on the Company’s balance sheet.
Research
and Development Costs
All
costs related to research and development are expensed when incurred. Research and development costs consist of expenses
associated with the development of the Company’s Power on Demand system and the Mobile Renewable Power Station. Specifically,
these costs consist of labor, materials, and consulting.
Warranty
Costs
The
Company’s standard warranty on each Power on Demand system, wind turbine, and solar system sold protects against defects
in design, material, and workmanship under normal use for varying periods, based upon the product sold. Several warranties
have specific additional terms and conditions. The Company provides for estimated cost of warranties at the time the
revenue is recognized. Factors that affect the warranty reserve are projected cost of repair and/or replacement, component
life cycles, manufacturer’s warranty on component parts, and historical data. These estimates are reviewed quarterly and
are updated as new information becomes available. The impact of any change in estimates will be taken into account when analyzing
future warranty reserve requirements.
Stock-Based
Compensation
The
Company accounts for stock option awards granted under the Company’s Equity Incentive Plan in accordance with ASC 718. Under
ASC 718, compensation expense related to stock-based payments is recorded over the requisite service period based on the grant
date fair value of the awards. Compensation previously recorded for unvested stock options that are forfeited is reversed
upon forfeiture. The Company uses the Black-Scholes option pricing model for determining the estimated fair value for
stock-based awards. The Black-Scholes model requires the use of assumptions which determine the fair value of stock-based awards,
including the option’s expected term and the price volatility of the underlying stock.
The
Company’s accounting policy for equity instruments issued to consultants and vendors in exchange for goods and services
follows the provisions of ASC 505-50. Accordingly, the measurement date for the fair value of the equity instruments
issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is
reached or (ii) the date at which the consultant’s or vendor’s performance is complete. In the case of equity
instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement,
or over the specified vesting period.
Income
Taxes
The
Company accounts for income taxes using the asset and liability approach, which requires recognition of deferred tax liabilities
and assets for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of
such assets and liabilities. This method utilizes enacted statutory tax rates in effect for the year in which the temporary
differences are expected to reverse and gives immediate effect to changes in income tax rates upon enactment. Deferred
assets are recognized, net of any valuation allowance, for temporary differences and net operating loss and tax credit carry forwards. Deferred
income tax expense represents the change in net deferred assets and liability balances.
Basic
and Diluted Loss Per Share
Basic
earnings per share reflect the actual weighted average of shares issued and outstanding during the period. Diluted
earnings per share are computed including the number of additional shares that would have been outstanding if dilutive potential
shares had been issued. In a loss period, the calculation for basic and diluted earnings per share is considered to
be the same, as the impact of potentially issued common shares would be anti-dilutive.
As of June 30, 2014, 1,415 shares of our Series A Convertible
Preferred Stock, convertible into 7,075,000 shares of common stock, 2,477,108 stock options and 18,292,916 warrants were outstanding
which, upon exercise, could dilute future earnings per share. Diluted Weighted Average Shares reflect the Company’s total
weighted average shares outstanding during the period, which includes the conversion of the Series A Convertible Preferred Stock
as well as any stock options or warrants in which the exercise price is below the Company’s stock trading price, less the
stock that can be repurchased with funds received from such exercise.
Note
2 - Going Concern
The financial statements have been prepared assuming that
the Company will continue as a going concern. Since its formation, the Company utilized funds generated from private
placement offerings and debt to fund its product development and operations and has incurred a cumulative net loss of $25,958,830
as of June 30, 2014. The recurring losses from operations and current liquidity raise substantial doubt about the Company’s
ability to continue as a going concern. Continuation of the Company is dependent on achieving sufficiently profitable
operations and obtaining additional financing.
Note
3 – Debt
On September 4, 2012, the Company entered into an unsecured
loan agreement with TMK-ENT, Inc. that provided for a $500,000 working capital revolving line of credit. Advances under
the line of credit bear interest at 10% per year, payable annually. On November 13, 2012, the Company amended its loan agreement
to increase the revolving line of credit from $500,000 to $750,000, and on December 21, 2012 amended its loan agreement to increase
the revolving credit from $750,000 to $1,250,000. The note matures on December 21, 2014. Borrowings under the line
of credit amount to $1,018,500 as of June 30, 2014 and December 31, 2013. In conjunction with the line of credit facility, the
Company issued 1,250,000 warrants to purchase the Company’s common stock at varying prices from $1.38 to $1.62 per share.
The warrants vested one year from issuance and have a ten year term. The fair market value of the warrants at grant date was determined
utilizing the Black Scholes option pricing model and amounted to $1,839,250. The difference between the fair market value of the
warrants and draws on the line of credit is $820,750 as of June 30, 2014 and December 31, 2013, which is recorded as deferred
debt discount. The deferred debt discount will be recognized and recorded as debt discount as the Company continues
to borrow against the line of credit. Debt discount costs will be recognized as the Company draws down the available line of credit,
and will be amortized over the remaining term of the loan. As a result of the amortization of the debt discount, the Company expensed
$170,522 and $354,554, respectively, for the six months ended June 30, 2014 and 2013 and $85,732 and $154,702 for the three months
ended June 30, 2014 and 2013.
Annual
maturities of debt are as follows:
2014 (includes TMK-ENT, Inc. line of credit repayment)
|
|
$
|
1,025,056
|
|
2015
|
|
$
|
9,540
|
|
2016
|
|
$
|
6,629
|
|
Note
4 – Stockholders’ Equity
On
March 31, 2014, the Company sold, pursuant to a securities purchase agreement, an aggregate of 1,500 shares of Series A Convertible
Preferred Stock, with a stated value of $1,500,000 that are convertible into shares of the Company’s common stock at a conversion
price of $0.20 in stated value per share (7,500,000 shares of common stock), and five-year warrants, which vested in full upon
issuance, to purchase up to 11,250,000 additional shares of common stock at a purchase price of $0.25 per share to 8 institutional
investors. Stock offering costs for the private placement amounted to $100,000. Each share of Preferred Stock is entitled to cash
interest payments of 9% of the stated value per year, payable quarterly. The Preferred Stock is voluntarily and mandatorily convertible
into shares of common stock pursuant to the provisions of the securities purchase agreement, with any shares of Preferred Stock
outstanding on March 31, 2017 automatically converting into common stock. The investors received rights of first refusal and rights
of participation in future financings of the Company until March 31, 2015. In addition, the investors received most favored nation
protections on the terms and conditions of the warrants and preferred stock so long as such securities remain outstanding. Additionally,
until September 30, 2015, each investor has the right to invest an amount equal to the amount invested by such investor in the
above-referenced transaction in preferred stock of Arista Power on substantially similar terms. The Preferred Stock and warrants
have customary anti-dilution protections and registration rights including a “full ratchet” anti-dilution adjustment
provision. The warrants associated with this transaction were valued at their date of issue utilizing the Black-Scholes option
pricing model, which amounted to $2,868,750. The difference between the warrants valuation of $2,878,560 and the net
proceeds received by the Company of $1,400,000 results in a deemed dividend of $1,468,750, which has been charged to additional
paid-in-capital, as the Company has no retained earnings from which to declare a dividend.
On March 31, 2014, in conjunction with the full ratchet
and anti-dilution provisions of the July and August 2013 private placement of common stock, shareholders were awarded an additional
1,255,000 shares of common stock and 612,000 warrants to purchase common stock for $0.25 per share, and the exercise price for
the 3,060,000 warrants outstanding that were associated with this transaction were reduced to $0.25 per warrant.
Note
5 – Stock Based Compensation
The Company has established the 2008 Equity Incentive Plan,
which is a shareholder-approved plan that permits the granting of stock options and restricted stock to employees, directors and
consultants. The 2008 Equity Incentive Plan provides for the issuance of up to 3,550,000 shares of common stock of
which 50,000 shares are available for grant as Incentive Stock Options. The exercise price for options awarded is no
less than 100% of the fair market value of the common stock on the day of grant. The options generally vest either
immediately on the date of grant or one to three years from the date of grant.
For the six and three months ended June 30, 2014, the Company recorded compensation
costs for options and warrants of $111,994 and $41,040 respectively, as compared to $539,391 and $176,022 for the six and three
months ended June 30, 2013. For the six months ended June 30, 2013, compensation costs relating to the issuance of options and
warrants amounted to $463,193 and the Company recorded an expense of $76,198 associated with the repricing of options and warrants
held by a former consultant/outside counsel who is now an employee of the Company, while for the six months ended June 30, 2014,
there was no expense associated with the repricing of options or warrants.
The
Company has valued the options at their date of grant utilizing the Black Scholes option pricing model. Prior to the
fourth quarter of 2009, there was not a public market for the Company shares. Accordingly, the fair value of the underlying
shares was determined based on recent transactions by the Company to sell shares to third parties and other factors determined
by management to be relevant to the valuation of such shares. Beginning in the fourth quarter of 2009, the quoted price
for the Company’s shares on the OTCBB was used to value the underlying shares. Expected volatility is based upon
a weighted average historical volatility of peer companies operating in a similar industry. The risk-free interest
rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of
the options depending on the date of the grant and expected life of the options. The expected life of options used
was based on the contractual life of the option granted. The Company determined the expected dividend rate based on
the assumption and expectation that earnings generated from operations are not expected to be adequate to allow for the payment
of dividends in the near future. The following weighted-average assumptions were utilized in the fair value calculations
for options granted:
|
|
Six Months
Ended
|
|
|
Six Months
Ended
|
|
|
|
June
30,
2014
|
|
|
June
30,
2013
|
|
|
|
|
|
|
|
|
Expected
dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected
stock price volatility
|
|
|
112
|
%
|
|
|
108
|
%
|
Risk-free
interest rate
|
|
|
2.53-3.63
|
%
|
|
|
2.68-2.82
|
%
|
Expected
life of options
|
|
10 years
|
|
|
.7-9.9 years
|
|
The
following table summarizes the status of the Company’s aggregate stock options granted:
|
|
Number of Shares Remaining Options
|
|
|
Weighted
Average
Exercise
Price
|
|
Weighted-
Average Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at January 1, 2014
|
|
|
1,386,108
|
|
|
$
|
.61
|
|
|
|
|
|
Options granted during 2014
|
|
|
1,365,000
|
|
|
$
|
.19
|
|
9.8 years
|
|
$
|
|
Options cancelled or expired during
2014
|
|
|
(274,000
|
)
|
|
|
.56
|
|
|
|
|
|
Outstanding at June
30, 2014
|
|
|
2,477,108
|
|
|
$
|
.38
|
|
8.8
years
|
|
$
|
|
|
Exercisable at June 30, 2014
|
|
|
703,808
|
|
|
$
|
.64
|
|
6.8 years
|
|
$
|
|
|
For the six and three months ended June 30, 2014, the Company recorded compensation costs for options granted
under the plan of $ 93,457 and $24,608, as compared to $170,060 and 9,309 for the six and three months ended June 30, 2013. Stock
option grants amounted to 1,365,000 for the six months ended June 30, 2014 (140,625 for the six months ended June 30, 2013) while
210,000 options vested during that period (147,275 options vested for the six months ended June 30, 2013). There were 274,000
options cancelled or expired for the six months ended June 30, 2014, while 1,000 options were cancelled for the six months ended
June 30, 2013. No options were exercised for the six months ended June 30, 2014 or June 30, 2013.
The weighted average fair value of options granted during
the six months ended June 30, 2014 was $0.19 per share, compared to $1.11 per share for the six months ended June 30, 2013.
For the six months ended June 30, 2013,
the Company recorded expenses totaling $13,575 associated with the repricing of 25,000 options awarded to a former consultant/outside
counsel who is now an employee of the Company. No such expense was recorded for the six months ended June 30, 2014.
On December 13, 2010, the Board of Directors approved a
restricted stock grant award to certain employees in lieu of future salary cash payments. The employees forfeited salary
over a twelve-week period to purchase common shares, which were valued at fair market value as of the date of grant. The
Compensation Committee of the Company’s Board of Directors have approved a change in the vesting date for restricted stock
held by certain employees from April 1, 2011 to April 1, 2015. A total of 55,969 shares vested on April 1, 2011, and 118,377 shares
remain outstanding and are scheduled to vest on April 1, 2015.
On March 31, 2014, Adeeb Saba was named Chief Operating
Officer and the Compensation Committee awarded him 250,000 shares of restricted common stock pursuant to the Company’s 2008
Equity Incentive Plan, which will vest one half each on the first and second anniversary of the award. Compensation costs associated
with this award amount to $72,500 and will be recognized over the vesting period of the stock. On May 28, 2014 the Compensation
Committee awarded an employee 100,000 shares of restricted common stock pursuant to the Company’s 2008 Equity Incentive
Plan, which will vest one half each on March 31, 2015 and March 31, 2016. Compensation costs associated with this award amount
to $15,000 and will be recognized over the vesting period of the stock. On June 16, 2014, Stephen Brown was named as the acting
Chief Financial Officer and the Compensation Committee awarded him 50,000 shares of restricted common stock pursuant to the Company’s
2008 Equity Incentive Plan, of which 10,000 shares vested immediately and the remaining 40,000 shares shall vest on December 16,
2014. Compensation costs associated with this award amount to $9,000 and will be recognized over the vesting period of the stock.
The following table summarizes the status of the Company’s
restricted common stock awards:
Restricted Shares
|
|
Number of
Restricted Shares
|
|
|
Weighted Average
Fair Value at
Grant Date
|
|
Non-vested at March 31, 2014
|
|
|
118,378
|
|
|
$
|
2.80
|
|
Awarded during 2014
|
|
|
400,000
|
|
|
|
.23
|
|
Cancelled or expired
|
|
|
(38,296
|
)
|
|
$
|
.92
|
|
Non-vested at March 31, 2014
|
|
|
480,082
|
|
|
$
|
.92
|
|
The compensation expense related to these grants were $16,432
for the six months ended June 30, 2014. There was no expense for the six months ended June 30, 2013.
Note
6 – Warrants
The
Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. The risk-free interest
rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of
the warrants depending on the date of the issue and their expected life. The expected life of warrants used was based
on the term of the warrant. The Company determined the expected dividend rate based on the assumption and expectation
that earnings generated from operations are not expected to be adequate to allow for the payment of dividends in the near future. The
following weighted-average assumptions were utilized in the fair value calculations for warrants granted:
|
|
Six
Months Ended
|
|
|
Six
Months Ended
|
|
|
|
June
30,
2014
|
|
|
June
30,
2013
|
|
Expected
dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected
stock price volatility
|
|
|
134
|
%
|
|
|
93-108
|
%
|
Risk-free
interest rate
|
|
|
1.73-1.75
|
%
|
|
|
.14–2.60
|
%
|
Expected
life of warrants
|
|
4.1-8.8 years
|
|
|
.6-9.6 years
|
|
The
following table summarizes the status of the Company’s warrants granted:
|
|
Number
of Shares Remaining Warrants
|
|
|
Weighted
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding
at January 1, 2014
|
|
|
7,671,267
|
|
|
$
|
1.51
|
|
|
|
|
|
Warrants
granted during 2014
|
|
|
11,862,000
|
|
|
$
|
.25
|
|
|
|
|
|
Warrants
expired during 2014
|
|
|
(1,240,351
|
)
|
|
|
.50
|
|
|
|
|
|
Outstanding
at March 31,2014
|
|
|
18,292,916
|
|
|
$
|
.78
|
|
5.1
years
|
|
$
|
0
|
|
Exercisable
at March 31,2014
|
|
|
18,139,250
|
|
|
$
|
.75
|
|
5.4
years
|
|
$
|
0
|
|
The weighted average fair value of warrants issued during the six months ended
June 30, 2014 and 2013 was $.25 and $.95, respectively. During the six months ended June 30, 2014, 11,878,000 warrants
vested (658,625 vested for the six months ended June 30, 2013), and 1,240,351 warrants expired. No warrants expired for the six
months ended June 30, 2013.
For
the six months ended June 30, 2014 and 2013, respectively, the Company recorded compensation costs of $4,962 and $293,133 for
warrants issued to a consultant (now an employee) of the Company. The warrants have a ten year life, a $1.20 exercise
price, and vest from six months to three years from grant date.
For the six months ended June 30, 2013, the Company recorded expenses totaling $62,623 associated with the repricing
of 423,125 outstanding warrants awarded to a former consultant/outside counsel who is now an employee of the Company. No
such expense was recorded for the six months ended June 30, 2014.
Note
7 – Derivative Liabilities
Certain warrants issued by the Company do not have fixed
settlement provisions because their exercise prices may be lowered if the Company issues securities at lower prices in the future,
are classified as derivative liabilities, and are revalued at each reporting date. These warrants include (1) warrants issued
to 1999 Mt RB, LLC in conjunction with our lease modification on February 4, 2013, which expired on February 4, 2014 (2) warrants
issued in conjunction with the Company’s strategic advisory agreement with Sunrise Financial Group, Inc. on May 21, 2013,
which were cancelled on June 19, 2014 and (3) warrants issued in conjunction with the Company’s private placements on July
31, 2013, August 6, 2013 and March 31, 2014. The reset provisions protect the warrant holders from the potential dilution associated
with future financings.
The
Company has valued warrants at their date of issue utilizing the Black-Scholes option pricing model. Expected volatility is based
upon a weighted average historical volatility of peer companies operating in a similar industry, or if applicable based upon the
term of the warrant, based upon the Company’s historical volatility. The risk-free interest rate is based on the implied
yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the warrants depending on the
date of the issue and their expected life. The expected life of warrants used was based on the term of the warrant. The Company
determined the expected dividend rate based on the assumption and expectation that earnings generated from operations are not
expected to be adequate to allow for the payment of dividends in the near future. The following weighted-average assumptions were
utilized in the fair value calculations for warrants granted and subsequent revaluation:
|
Six Months Ended
|
|
Six Months Ended
|
|
|
June 30,
2014
|
|
June 30,
2013
|
|
Expected dividend yield
|
0%
|
|
|
0
|
%
|
Expected stock price volatility
|
142%
|
|
|
96-97
|
%
|
Risk-free interest rate
|
1.62%
|
|
|
.84-1.41
|
%
|
Expected life of warrants
|
3.2-4.8 years
|
|
4.9-5.0 years
|
|
Number of warrants
|
14,922,000
|
|
|
640,351
|
|
Fair value of warrants
|
$
|
1,705,766
|
|
$
|
317,614
|
|
The fair value of these warrant liabilities was $1,705,766
at June 30, 2014. The change in fair value for the six months ended June 30, 2014 was $2,090,356 and is reported in our statement
of operations as an unrealized gain on the change in fair value of the derivative liabilities. For the six months ended June 30,
2013, we recorded an unrealized loss on the change in fair value of the derivative liabilities totaling $18,250. The fair value
of the derivative liabilities are re-measured at the end of every reporting period and upon the exercise of the warrant.
In June 2014 the advisory agreement with Sunrise Financial
Group was terminated and its accompanying warrants were cancelled.
Fair
Value Measurement
Valuation
Hierarchy
ASC
820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to
valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs
are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar
assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly
through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs
based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s
classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
The
following table provides the liabilities carried at fair value measured on a recurring basis as of June 30, 2014:
|
|
|
|
|
Fair Value Measurements at
June 30, 2014
|
|
|
|
Total
Carrying
Value at
June 30,
2014,
|
|
|
Quoted
prices in
active
markets
(Level 1)
|
|
|
Significant
other
observable
inputs
(Level 2)
|
|
|
Significant
unobservable
inputs
(Level 3)
|
|
Derivative liabilities
|
|
$
|
1,705,766
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,705,766
|
|
The
derivative liabilities are measured at fair value using quoted market prices and estimated volatility factors, and are classified
within Level 3 of the valuation hierarchy.
The
following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at
fair value on a recurring basis:
|
|
Year ended
December 31,
2013
|
|
Beginning balance January 1, 2014
|
|
$
|
775,596
|
|
Issuance of derivative financial instruments in 2014
|
|
|
3,020,526
|
|
Net unrealized (gain) loss on derivative financial instruments
|
|
|
(2,090,356
|
)
|
Ending balance as of June 30, 2014
|
|
$
|
1,705,766
|
|
Note
8- Recent Accounting Pronouncements
The Company has considered recent accounting pronouncements
including FASB Update 2014-12 regarding stock compensation based on performance and FASB Update 2014-09 updating revenue recognition
rules and believes that these recent pronouncements will not have a material effect on the Company’s financial statements.